Background illustration for clinical trials search

Paid Clinical Trials Worcester

Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Pediatric Acute Gastrointestinal Bleeding Registry

for
Upper Gastrointestinal Bleeding, Gastro Intestinal Bleeding
Location: Boston MA, Chicago IL, Houston TX
Sponsor: Boston Children's Hospital

Sex: All

Age: 0 - 21

Code: NCT03090945

Recruiting

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

for
Intracranial Meningioma
Location: Boston MA, New Haven CT, New York NY, Durham NC,
Sponsor: RTOG Foundation, Inc.

Sex: All

Age: 18+

Code: NCT06955169

Phase2, Recruiting

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumor, Melanoma, HNSCC, Sarcoma, Squamous Cell Carcinoma,
Location: Boston MA, Fairfax VA, Pittsburgh PA, Dallas TX
Sponsor: ImmVira Pharma Co. Ltd

Sex: All

Age: 18+

Code: NCT04370587

Phase1, Phase2, Recruiting

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

for
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06138587

Phase1, Recruiting

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

for
Breast Neoplasms, Breast Cancer
Location: Boston MA, New Brunswick NJ, Montreal, Kingston,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06686394

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Comparison of Uncomplicated Candidemia Therapy Duration in Children

for
Invasive Candidiasis
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0+

Code: NCT05763251

Recruiting

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

for
Hematopoietic Cell Transplant, Solid Organ Transplant,
Location: Boston MA, The Bronx NY, Washington D.C. DC,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0 - 18

Code: NCT05550298

Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Boston MA, Mineola NY, New York NY, East Brunswick NJ,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase1, Recruiting

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

for
Breast Cancer, Stage III Breast Cancer, Breast Cancer Female,
Location: Boston MA, State College PA, Pittsburgh PA,
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 65+

Code: NCT05535192

Recruiting

Reversible Effect of Falling Ventilatory Drive in Drive-dependent OSA

for
OSA
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 21 - 70+

Code: NCT06091098

Recruiting

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

for
BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation,
Location: Boston MA, New York NY, Philadelphia PA, Durham NC,
Sponsor: University Medical Center Nijmegen

Sex: Female

Age: 25 - 50

Code: NCT04294927

Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for
Myelofibrosis
Location: Boston MA, New Haven CT, The Bronx NY, Hackensack NJ,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase1, Phase2, Recruiting

A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

for
Primary Myelofibrosis
Location: Boston MA, New York NY, Columbus OH, Ann Arbor MI,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06343805

Phase1, Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Boston MA, Baltimore MD, Washington D.C. DC, Fairfax VA,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase2, Recruiting

Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

for
Hiv, Substance Use Disorders
Location: Boston MA, Miami FL
Sponsor: Boston University

Sex: All

Age: 18+

Code: NCT05934305

Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, New Haven CT, Shirley NY, Lebanon NH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

Patient Navigation to Improve Patient-Centered Cancer Care

for
Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT03226405

Recruiting

Prostate Cancer Genetic Risk Evaluation and Screening Study

for
Prostatic Neoplasm, Prostate Cancer, BRCA2 Mutation,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Male

Age: 35 - 70+

Code: NCT05129605

Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

for
Coronary Artery Disease
Location: Boston MA, Valhalla NY, Englewood NJ, New York NY,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06399705

Phase3, Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Providence RI, Boston MA, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase2, Recruiting